Cardiovascular Journal of Africa: Vol 26 No 4 (July/August 2015)

24 / 78

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 4, July/August 2015 170 AFRICA
References
1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent
risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983–988.
2. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP,
et al . Secular trends in incidence of atrial fibrillation in Olmsted County,
Minnesota, 1980 to 2000, and implications on the projections for future
prevalence. Circulation 2006; 114: 119–125.
3. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et
al . Spontaneous initiation of atrial fibrillation by ectopic beats originating
in the pulmonary veins. N Engl J Med 1998; 339: 659–666.
4. Sanders P, Berenfeld O, Hocini M, Jaïs P, Vaidyanathan R, Hsu LF, et al.
Spectral analysis identifies sites of high-frequency activity maintaining
atrial fibrillation in humans. Circulation 2005; 112: 789–797.
5. Lin YJ, Tsao HM, Chang SL, Lo LW, Hu YF, Chang CJ, et al. Role of
high dominant frequency sites in nonparoxysmal atrial fibrillation patients:
insights from high-density frequency and fractionation mapping. Heart
Rhythm 2010; 7: 1255–1262.
6. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et
al . 2012 HRS/EHRA/ECAS expert consensus statement on catheter and
surgical ablation of atrial fibrillation: recommendations for patient selec-
tion, procedural techniques, patient management and follow-up, defini-
tions, endpoints, and research trial design. Europace 2012; 14: 528–606.
7. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN,
et al. Detection and quantification of left atrial structural remodeling with
delayed‐enhancement magnetic resonance imaging in patients with atrial
fibrillation. Circulation 2009; 119: 1758–1767.
8. Fürnkranz A, Chun KRJ, Nuyens D, Metzner A, Ko¨ster I, Schmidt B, et
al. Characterization of conduction recovery after pulmonary vein isolation
using the ‘single big cryoballoon’ technique. Heart Rhythm 2010; 7: 184–190.
9. Ernst S, Ouyang F, Lober F, Antz M, Kuck KH. Catheter-induced linear
lesions in the left atrium in patients with atrial fibrillation: an electroana-
tomic study. J Am Coll Cardiol 2003; 42: 1271–1282.
10. Jais P, Hocini M, Hsu LF, Sanders P, Scavee C, Weerasooriya R, et al.
Technique and results of linear ablation at the mitral isthmus. Circulation
2004; 110: 2996–3002.
11. Pappone C, Manguso F, Vicedomini G, Gugliotta F, Santinelli O, Ferro
A, et al. Prevention of iatrogenic atrial tachycardia after ablation of atrial
fibrillation: a prospective randomized study comparing circumferential
pulmonary vein ablation with a modified approach. Circulation 2004; 110:
3036–3042.
12. Hocini M, Jais P, Sanders P, Takahashi Y, Rotter M, Rostock T, et al.
Techniques, evaluation, and consequences of linear block at the left atrial
roof in paroxysmal atrial fibrillation: a prospective randomized study.
Circulation 2005; 112: 3688–3696.
13. Katritsis DG, Hossein-Nia M, Anastasakis A, Poloniecki J, Holt DW,
Camm AJ, et al. Myocardial injury induced by radiofrequency and low
energy ablation: a quantitative study of CK isoforms, CK-MB, and
troponin-T concentrations. Pacing Clin Electrophysiol 1998; 21: 1410–1416.
14. Madrid AH, del Rey JM, Rubi J, Ortega J, Gonzalez Rebollo JM, Seara
JG, et al. Biochemical markers and cardiac troponin I release after radi-
ofrequency catheter ablation: approach to size of necrosis. Am Heart J
1998; 136: 948–955.
15. Oswald H, Gardiwal A, Lissel C, Yu H, Klein G. Difference in humoral
biomarkers for myocardial injury and inflammation in radiofrequency
ablation versus cryoablation. Pacing Clin Electrophysiol 2007; 30: 885–890.
16. Kuhne M, Suter Y, Altmann D, Ammann P, Schaer B, Osswald S,
Sticherling C. Cryoballoon versus radiofrequency catheter ablation of
paroxysmal atrial fibrillation: biomarkers of myocardial injury, recurrence
rates, and pulmonary vein reconnection patterns. Heart Rhythm 2010; 7:
1770–1776.
17. Wojcik M, Janin S, Kuniss M, Berkowitsch A, Erkapic D, Zaltsberg S, et al.
Limitations of biomarkers serum levels during pulmonary vein isolation.
Rev Esp Cardiol 2011; 64: 127–132.
18. Wojcik M, Janin S, Neumann T, Kuniss M, Berkowitsch A, Erkapic D, et
al. Which Standard biomarkers are useful for the evaluation of myocardial
injury after pulmonary vein isolation with cryoballoon? Kardiol Pol 2011;
69: 1151–1155.
19. Casella M, Dello Russo A, Russo E, Al-Mohani G, Santangeli P, Riva S,
et al. Biomarkers of myocardial injury with different energy sources for
atrial fibrillation catheter ablation. Cardiol J 2014, Mar 27, [E-pub ahead
of print].
20. Siklody CH, Arentz T, Minners J, Jesel L, Stratz C, Valina CM, et al .
Cellular damage, platelet activation, and inflammatory response after
pulmonary vein isolation: a randomized study comparing radiofrequency
ablation with cryoablation. Heart Rhythm 2012; 9: 189–196.
21. Manolis AS, Vassilikos V, Maounis T, Melita-Manolis H, Psarros L,
Haliasos A, Cokkinos DV. Detection of myocardial injury during radi-
ofrequency catheter ablation by measuring serum cardiac troponin I levels:
procedural correlates. J Am Coll Cardiol 1999; 34: 1099–1105.
22. Alaiti AM, Maroo A, Edel TB. Troponin levels after cardiac electrophysi-
ology procedures: review of the literature. Pacing Clin Electrophysiol 2009;
32: 800–810.
23. Whittaker DK. Mechanisms of tissue destruction following cryosurgery.
Ann R Coll Surg Engl 1984; 66: 313–318.
24. Wood MA, Parvez B, Ellenbogen AL, Shaffer KM, Goldberg SM, Gaspar
MP, et al. Determinants of lesion sizes and tissue temperatures during
catheter cryoablation. Pacing Clin Electrophysiol 2007; 30: 644–654.
25. Parvez B, Pathak V, Schubert CM, Wood M. Comparison of lesion sizes
produced by cryoablation and open irrigation radiofrequency ablation
catheters. J Cardiovasc Electrophysiol 2008; 19: 528–534.
26. Guler TE, Aksu T, Golcuk SE, Erden I (abstract) Is achievement of sinus
rhythm really delusion in long-lasting persistent atrial fibrillation? Anadolu
Kardiyol Derg 2014; 14(Suppl. 1): 68.
27. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al.
Guidelines for the management of atrial fibrillation: the Task Force for the
Management of Atrial Fibrillation of the European Society of Cardiology
(ESC). Europace 2010; 12: 1360–1420.
28. Packer DL, Kowal RC, Wheelan KR, Irwin JM, Champagne J, Guerra
PG, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial
fibrillation: first results of the North American Arctic Front (STOP AF)
pivotal trial. J Am Coll Cardiol 2013; 61: 1713–1723.
29. Verma A, Novak P, Macle L, Whaley B, Beardsall M, Wulffhart Z,
Khaykin Y. A prospective, multicenter evaluation of ablating complex
fractionated electrograms (CFEs) during atrial fibrillation (AF) identified
by an automated mapping algorithm: acute effects on AF and efficacy as
an adjuvant strategy. Heart Rhythm 2008; 5: 198–205.
30. Dorwarth U, Schmidt M, Wankerl M, Krieg J, Straue F, Hoffmann E.
Pulmonary vein electrophysiology during cryoballoon ablation as a predic-
tor for procedural success. J Interv Card Electrophysiol 2011; 32: 205–211.
31. Aytemir K, Gurses KM, Yalcin MU, Kocyigit D, Dural M, Evranos B,
et al. Safety and efficacy outcomes in patients undergoing pulmonary
vein isolation with second-generation cryoballoon. Europace 2014; [E-pub
ahead of print].
32. del Rey JM, Madrid AH, Vali ńo JM, Rubi J, Mercader J, Moro C, Ripol
E. Cardiac troponin I and minor cardiac damage: biochemical markers in
a clinical model of myocardial lesions. Clin Chem 1998; 44: 2270–2276.
33. Bordignon S, Fürnkranz A, Dugo D, Perrotta L, Gunawardene M, Bode
F, et al. Improved lesion formation using the novel 28 mm cryoballoon in
atrial fibrillation ablation: analysis of biomarker release. Europace 2014;
16: 987–993.